FDAnews Device Daily Bulletin

RITA ANNOUNCES LAUNCH OF LC BEAD EMBOLIZATION PRODUCT IN U.S.

July 12, 2006
A A

RITA Medical Systems, Inc., a publicly-traded medical device company focused solely on cancer therapies, today announced the Company has begun sales of the LC Bead in the United States. The new product is a minimally invasive embolization treatment for hypervascular tumors that blocks the blood flow feeding a tumor, causing it to shrink in size over time. Embolization is commonly used to treat hepatocellular carcinoma, the most common form of primary liver cancer, as well as neuroendocrine tumors.

Yahoo News (http://biz.yahoo.com/prnews/060711/sftu050.html?.v=61)